Jennifer Sarah Davis
Works at
University of Kansas Medical Center
Assistant professor
Sources: reporter.nih.gov
Grants and prizes
R21, Testing the effects of tirzepatide on colorectal cancer incidence and outcomes in a mouse model, R21CA313262, 2026–2028, Jul 7, 2026
U01, Colorectal cancer risk factors, risk prediction and blood-based biomarker by tumor consensus molecular subtype, U01CA222163, 2019–2025, May 6, 2022
Sources: reporter.nih.gov